ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 145668 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 145668; 2) Community: the network communities that were significantly associated with the response to NSC 145668; 3) Molecule: the relationships between components within communities and NSC 145668; 4) MDR: the compounds that were significantly associated with the NSC 145668.

NSC Compound Enrichment Correlation
NSC 143095 Pyrazofurin 0.0152777849043087 0.48421903
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0164116791870036 0.39880835
NSC 303812 Aphidicoline glycinate 0.0164116791870036 0.71856686
NSC 3077 s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.0164116791870036 0.39019132
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0164116791870036 0.64041963
NSC 354974 Acetamide, N-(5,6,7,9-tetrahydro-2,3-dihydroxy-1,10-dimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.0164116791870036 0.038245526
NSC 371777 Null 0.0164116791870036 0.12759008
NSC 45236 Null 0.0164116791870036 0.13945242
NSC 603071 Aminocamptothecin 0.0164116791870036 0.63611626
NSC 614887 Platinum, (1,2-cyclohexanediamine-N,N')bis (4-morpholinepropanesulfonato-O)-, (SP-4-2) 0.0164116791870036 0.46924035
Total:110  Current:38    [First] [Prev] [Next] [Last]